Peer Reviewed Publications

Deerland makes significant investments in clinical research to support the safety and efficacy of its probiotic, prebiotic and enzyme-based branded ingredients.

Bacillus subtilis DE111® Clinical Studies

More than 30 studies have been performed to confirm the safety and efficacy of Bacillus subtilis DE111. A full genome sequencing confirmed the strain contained no plasmids, antibiotic resistant or deleterious genes.

Digestion

Regularity

Immune Health

Sports Performance, Body Composition and Recovery

Cardiovascular Health

Children’s Microbiome & Immune Health

Germination

ProHydrolase Clinical Studies

Numerous in vitro studies plus two separate human clinical studies have shown the superior ability of ProHydrolase to quickly break down protein, increase available amino acids in the blood, decrease C-reactive protein levels and decrease the large peptides associated with stomach discomfort that results from consuming protein.

PreForPro® Clinical Studies

More than 20 studies have been performed to confirm the safety and efficacy of PreforPro. In-vitro and in-vivo tests have demonstrated the growth-promoting effect of PreforPro on beneficial bacterial strains of Lactococcus, Lactobacillus, Bifidobacterium and Bacillus subtilis when competing with undesirable bacterial strains. In a human clinical study, PreforPro was shown to influence the microbial population of the gut, without disrupting the global microbiota.

 

Glutalytic Clinical Studies

Numerous in vitro studies plus two separate human clinical studies have shown the superior ability of Glutalytic to quickly break down gluten proteins, effectively reducing the frequency and severity of symptoms associated with gluten sensitivity. Glutalytic is also clinically proven to reduce levels of IgA and CRP, supporting a proper immune response.

Additional Published Studies

Subscribe to Digestible

An educational enzyme and probiotic resource
Sign Up